Increased LINGO1 in the cerebellum of essential tremor patients

Movement Disorders

Volumn 29, Issue 13, 2014, Pages 1637-1647

  Delay, Charlotte ^a,b   Tremblay, Cyntia ^a,b   Brochu, Elodie ^a,b   Paris Robidas, Sarah ^a,b   Emond, Vincent ^a,b   Rajput, Ali H ^c   Rajput, Alex ^c   Calon, Frédéric ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Cerebellum; Dentate nucleus; Essential tremor; LINGO; Neurodegeneration

Indexed keywords

LINGO1 PROTEIN; LINGO2 PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; LINGO1 PROTEIN, HUMAN; NERVE PROTEIN;

ARTICLE; CEREBELLUM; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ESSENTIAL TREMOR; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MYELINATED NERVE; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING; WHITE MATTER; AGED; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBELLUM; ESSENTIAL TREMOR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; RNA, MESSENGER; WHITE MATTER;

EID: 84911434297     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25819     Document Type: Article

References (52)

1. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534-541.
2. Yu SW, Chen CM, Chen YC, et al. SLC1A2 Variant is associated with essential tremor in Taiwanese population [serial online]. PLoS One 2013;8:e71919.
3. Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009;41:277-279.
4. Thier S, Lorenz D, Nothnagel M, et al. LINGO1 polymorphisms are associated with essential tremor in Europeans. Mov Disord 2010;25:717-723.
5. Tan EK, Teo YY, Prakash KM, et al. LINGO1 variant increases risk of familial essential tremor. Neurology 2009;73:1161-1162.
6. Vilarino-Guell C, Wider C, Ross OA, et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010;11:401-408.
7. Clark LN, Park N, Kisselev S, Rios E, Lee JH, Louis ED. Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet 2010;18:838-843.
8. Wu YW, Rong TY, Li HH, et al. Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians. Acta Neurol Scand 2011;124:264-268.
9. Bourassa C V, Riviere J-B, Dion PA, Bernard G, Diab S, Panisset M, et al. LINGO1 variants in the French-Canadian population [serial online]. PLoS One 2011;6:e16254.
10. Zuo X, Jiang H, Guo JF, et al. Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson's disease in Chinese population. Neurosci Lett 2010;481:69-72.
11. Lorenzo-Betancor O, Samaranch L, Garcia-Martin E, et al.; Iberian Parkinson's Disease Genetics Study Group Researchers. LINGO1 gene analysis in Parkinson's disease phenotypes. Mov Disord 2011;26:722-727.
12. Jimenez-Jimenez FJ, Garcia-Martin E, Lorenzo-Betancor O, Pastor P, Alonso-Navarro H, Agundez JA. LINGO1 and risk for essential tremor: results of a meta-analysis of rs9652490 and rs11856808. J Neurol Sci 2012;317(1-2):52-57.
13. Wu YW, Prakash KM, Rong T-Y, et al. Lingo2 variants associated with essential tremor and Parkinson's disease. Hum Genet 2011;129:611-615.
14. Llorens F, Gil V, Iraola S, et al. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Dev Neurobiol 2008;68:521-541.
15. Homma S, Shimada T, Hikake T, Yaginuma H. Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr Patterns 2009;9:1-26.
16. Mi S, Miller RH, Lee X, et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005;8:745-751.
17. Lee X, Yang Z, Shao Z, et al. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci 2007;27:220-225.
18. Jepson S, Vought B, Gross CH, et al. LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions. J Biol Chem 2012;287:22184-22195.
19. Mi S, Hu B, Hahm K, et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007;13:1228-1233.
20. Loov C, Fernqvist M, Walmsley AR, Marklund N, Erlandsson A. Neutralization of LINGO-1 during in vitro differentiation of neural stem cells results in proliferation of immature neurons [serial online]. PLoS One 2012;7:e29771.
21. Ji B, Li M, Wu WT, et al. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol Cell Neurosci 2006;33:311-320.
22. Mi S, Sandrock A, Miller RH. LINGO-1 and its role in CNS repair. Int J Biochem Cell Biol 2008;40:1971-1978.
23. Inoue H, Lin L, Lee X, et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci U S A 2007;104:14430-14435.
24. Gerin CG, Madueke IC, Perkins T, et al. Combination strategies for repair, plasticity and, regeneration using regulation of gene expression during the chronic phase after spinal cord injury. Synapse 2011;65:1255-1281.
25. Llorens F, Gil V, del Rio JA. Emerging functions of myelin-associated proteins during development, neuronal plasticity, and neurodegeneration. FASEB J 2011;25:463-475.
26. Kuo SH, Tang G, Louis ED, et al. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol 2013;125:879-889.
27. Paris-Robidas S, Brochu E, Sintes M, et al. Defective dentate nucleus GABA receptors in essential tremor. Brain 2012;135(pt 1):105-116.
28. Rajput A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 2004;62:932-936.
29. Tremblay C, Pilote M, Phivilay A, Emond V, Bennett DA, Calon F. Biochemical characterization of AI2 and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2007;12:377-390.
30. Tremblay C, St-Amour I, Schneider J, Bennett DA, Calon F. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol 2011;70:788-798.
31. Julien C, Tremblay C, Bendjelloul F, Phivilay A, Coulombe MA, Emond V, Calon F. Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology. J Neurosci Res 2008;86:2292-2302.
32. Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007;130(pt 12):3297-3307.
33. Erickson-Davis CR, Faust PL, Vonsattel J-PG, Gupta S, Honig LS, Louis ED. "Hairy baskets" associated with degenerative Purkinje cell changes in essential tremor. J Neuropathol Exp Neurol 2010;69:262-271.
34. Shill HA, Adler CH, Sabbagh MN, Connor DJ, Caviness JN, Hentz JG, Beach TG. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 2008;70(16 pt 2):1452-1455.
35. Louis ED. Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem enquiry. Lancet Neurol 2010;9:613-622.
36. Kuo S-H, Erickson-Davis CR, Gillman A, Faust PL, Vonsattel J-PG, Louis ED. Increased number of heterotopic Purkinje cells in essential tremor. J Neurol Neurosurg Psychiatry 2011;82:1038-1040.
37. Louis ED, Vonsattel JP, Honig LS, Ross GW, Lyons KE, Pahwa R. Neuropathologic findings in essential tremor. Neurology 2006;66;1756-1759.
38. Louis ED, Vonsattel JP, Honig LS, Lawton A, Moskowitz CB, Ford B, Frucht S. Essential tremor associated with pathologic changes in the cerebellum. Arch Neurol 2006;63:1189-1193.
39. Louis ED, Vonsattel JP. The emerging neuropathology of essential tremor. Mov Disord 2008;23:174-182.
40. Harraz MM, Dawson TM, Dawson VL. MicroRNAs in Parkinson's disease. J Chem Neuroanat 2011;42:127-130.
41. Ebrahimi-Fakhari D, Wahlster L, McLean PJ. Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol 2012;142:153-172.
42. Axelrad JE, Louis ED, Honig LS, et al. Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol 2008;65:101-107.
43. Louis ED. Essential tremor. Lancet Neurol 2005;4:100-110.
44. Kurtis MM. Essential tremor: is it a neurodegenerative disease? No. J Neural Transm 2012;119:1375-1381; discussion 1373.
45. Bonuccelli U. Essential tremor is a neurodegenerative disease. J Neural Transm 2012;119:1383-1377; discussion 1373.
46. Rajput AH, Adler CH, Shill HA, Rajput A. Essential tremor is not a neurodegenerative disease. Neurodegener Dis Manag 2012;2:259-268.
47. Louis ED, Faust PL, Vonsattel JP. Purkinje cell loss is a characteristic of essential tremor: towards a more mature understanding of pathogenesis. Parkinsonism Relat Disord 2012;18:1003-1004.
48. Satoh J, Tabunoki H, Yamamura T, Arima K, Konno H. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2007;33:99-107.
49. Mi S, Lee X, Shao Z, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004;7:221-228.
50. Fu Q-L, Hu B, Wu W, Pepinsky RB, Mi S, So KF. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection. Invest Ophthalmol Vis Sci 2008;49:975-985.
51. Mi S, Miller RH, Tang W, et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009;65:304-315.
52. Pepinsky RB, Shao Z, Ji B, et al. Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration. J Pharmacol Exp Ther 2011;339:519-529.